We believe it is high time that we combine smart design, great technology and awesome customer care to give India a massive health and wellness boost
Together, all of these factors improve the general appearance of skin
Specific Trial Doses: The liposomal study tested 500 mg and 1,000 mg daily
For instance, semaglutide has been approved and is being researched for indications including obesity, T2DM, reducing cardiovascular risk, chronic kidney disease, NAFLD, and AD, indicating that the development of new indications could provide new growth opportunities for GLP-1 drugs
Leading & Fastest-growing Product Type : Reduced glutathione is the leading product segment with about 62% market share in 2025, owing to several critical advantages tied directly to its biological activity and consumer acceptance
Each item is formulated for all skin types, ensuring comfort and effectiveness